Raymond James & Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$18.4M Buy
1,020,719
+204,775
+25% +$3.69M 0.01% 858
2024
Q2
$13.3M Buy
815,944
+39,610
+5% +$644K 0.01% 1001
2024
Q1
$11M Buy
776,334
+569,621
+276% +$8.04M 0.01% 1101
2023
Q4
$2.16M Buy
206,713
+4,885
+2% +$51K ﹤0.01% 2047
2023
Q3
$2.06M Sell
201,828
-14,426
-7% -$147K ﹤0.01% 1999
2023
Q2
$1.63M Sell
216,254
-21,351
-9% -$161K ﹤0.01% 2173
2023
Q1
$2.1M Buy
237,605
+22,049
+10% +$195K ﹤0.01% 2000
2022
Q4
$1.97M Sell
215,556
-19,717
-8% -$180K ﹤0.01% 1997
2022
Q3
$1.9M Sell
235,273
-38,877
-14% -$314K ﹤0.01% 1994
2022
Q2
$2.06M Sell
274,150
-26,854
-9% -$202K ﹤0.01% 1957
2022
Q1
$2.83M Sell
301,004
-23,605
-7% -$222K ﹤0.01% 1891
2021
Q4
$2.6M Sell
324,609
-71,784
-18% -$575K ﹤0.01% 1984
2021
Q3
$3.86M Sell
396,393
-74,298
-16% -$724K ﹤0.01% 1663
2021
Q2
$4.66M Sell
470,691
-86,487
-16% -$856K ﹤0.01% 1532
2021
Q1
$6.43M Sell
557,178
-174,271
-24% -$2.01M 0.01% 1272
2020
Q4
$7.06M Buy
731,449
+234,643
+47% +$2.26M 0.01% 1138
2020
Q3
$4.48M Sell
496,806
-103,447
-17% -$932K 0.01% 1289
2020
Q2
$7.4M Sell
600,253
-95,242
-14% -$1.17M 0.01% 975
2020
Q1
$6.25M Buy
695,495
+133,691
+24% +$1.2M 0.01% 937
2019
Q4
$5.51M Sell
561,804
-100,218
-15% -$982K 0.01% 1187
2019
Q3
$4.56M Sell
662,022
-8,093
-1% -$55.7K 0.01% 1284
2019
Q2
$6.19M Buy
670,115
+164,720
+33% +$1.52M 0.01% 1105
2019
Q1
$7.93M Buy
505,395
+4,562
+0.9% +$71.5K 0.01% 941
2018
Q4
$7.72M Sell
500,833
-114,205
-19% -$1.76M 0.01% 876
2018
Q3
$13.2M Buy
615,038
+4,673
+0.8% +$101K 0.02% 699
2018
Q2
$14.8M Sell
610,365
-115,500
-16% -$2.81M 0.03% 630
2018
Q1
$12.4M Buy
725,865
+14,932
+2% +$255K 0.02% 671
2017
Q4
$13.5M Buy
710,933
+111,263
+19% +$2.11M 0.02% 623
2017
Q3
$10.6M Buy
599,670
+112,822
+23% +$1.99M 0.02% 705
2017
Q2
$16.2M Buy
486,848
+63,221
+15% +$2.1M 0.04% 511
2017
Q1
$13.6M Sell
423,627
-163,974
-28% -$5.26M 0.03% 538
2016
Q4
$21.3M Buy
587,601
+49,159
+9% +$1.78M 0.05% 342
2016
Q3
$24.8M Buy
538,442
+166,319
+45% +$7.65M 0.07% 282
2016
Q2
$18.7M Buy
372,123
+6,058
+2% +$304K 0.06% 332
2016
Q1
$19.6M Buy
366,065
+22,469
+7% +$1.2M 0.07% 313
2015
Q4
$22.6M Buy
343,596
+13,194
+4% +$866K 0.08% 269
2015
Q3
$18.7M Sell
330,402
-142,936
-30% -$8.07M 0.08% 283
2015
Q2
$28M Buy
473,338
+223,378
+89% +$13.2M 0.11% 208
2015
Q1
$15.6M Buy
249,960
+64,718
+35% +$4.03M 0.07% 311
2014
Q4
$10.7M Buy
185,242
+35,077
+23% +$2.02M 0.05% 387
2014
Q3
$8.07M Sell
150,165
-25,414
-14% -$1.37M 0.05% 427
2014
Q2
$9.2M Buy
175,579
+22,263
+15% +$1.17M 0.06% 385
2014
Q1
$8.1M Buy
153,316
+75,456
+97% +$3.99M 0.06% 390
2013
Q4
$3.12M Sell
77,860
-31,862
-29% -$1.28M 0.02% 730
2013
Q3
$4.15M Sell
109,722
-10,660
-9% -$403K 0.04% 548
2013
Q2
$4.72M Buy
+120,382
New +$4.72M 0.04% 452